The aim of the study was to determine whether a short-term treatment with simvastatin or
fenofibrate may result in beneficial anti-inflammatory and antithrombotic effects in patients with …

Introduction COVID-19 is associated with an increased thromboembolic risk. However, the
mechanisms triggering clot formation in those patients remain unknown. Patients and …

Background Antiphospholipid syndrome (APS) is characterized by the presence of circulating
antiphospholipid antibodies (aPL) in patients with thrombosis and/or pregnancy morbidity. …

Recently, we have reported that asthma is associated with enhanced plasma thrombin
formation and impaired fibrinolysis. The mechanisms underlying the prothrombotic state in this …

Introduction Antiphospholipid syndrome (APS) is associated with the risk of both arterial and
venous thrombosis. However, it is not known which factors might determine the location of …

Background There is evidence that altered blood coagulation and fibrinolysis are involved
in the pathogenesis of asthma. Increased thromboembolic risk has been reported in …

INTRODUCTION Inherited deficiencies of natural anticoagulants such as antithrombin (AT;
gene: SERPINC1), protein C (PC; PROC), and protein S (PS; PROS1), with the prevalence in …

Background Emerging data indicates that extracellular traps (ETs), structures formed by
various immune cell types, may contribute to the pathology of noninfectious inflammatory …

Introduction Central retinal artery occlusion (CRAO) is a common cause of blindness and
visual morbidity. In the majority of cases, it is related to thrombotic embolism. Nevertheless, the …

Introduction Several methods for measuring fibrinolytic capacity in plasma have been
developed yielding frequently inconsistent results. We investigated which factors determine …